Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Exercise/Conversion of 2,816 AGIO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 2,816 | n/a |
| Feb 18, 2026 | Enliven Therapeutics, Inc. (ELVN) | Grant/Award | 17,126 | n/a |
| Aug 13, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 2,302 | n/a |
| Jun 23, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 2,120 | n/a |
| Feb 10, 2025 | Enliven Therapeutics, Inc. (ELVN) | Grant/Award | 20,491 | n/a |
| Nov 12, 2024 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 10,000 | $259.9K |
| Oct 11, 2024 | Enliven Therapeutics, Inc. (ELVN) | Exercise/Conversion | 6,314 | $124.3K |
| Aug 13, 2024 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 2,302 | n/a |
| Jun 24, 2024 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Grant/Award | 2,120 | n/a |
| Jun 17, 2024 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 3,388 | n/a |